Sanoculis
Sanoculis

Sanoculis

DR11Ahrefs DR: 11/100. Bottom 25%. Measured by Ahrefs. Median 44.Agent21Agent Readiness: 21/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Speed84Site Speed: 84/100. Top 25%. Measured by Google PageSpeed. Median 62.Trust83Data Trust: 83/100. Top 25%. Measured by StartupHub.ai. Median 61.

Sanoculis develops MIMS®, a minimally invasive surgical device for glaucoma treatment, creating a drainage channel without implants or stitches.

2012Active10Tel Aviv, Israel

About

Sanoculis is a medical device startup focused on developing innovative solutions for glaucoma treatment. Their flagship product, MIMS® (Minimally Invasive Micro Sclerostomy), is a surgical device designed to create a drainage channel to reduce intraocular pressure (IOP) in glaucoma patients. The MIMS® procedure aims for a long-lasting, safe, and controlled fluid flow without the need for stitches, eye-patches, implants, or stents, thereby reducing post-surgical complications and care costs.

Key facts

Website
sanoculis.com
Headquarters
Tel Aviv, Israel
Founded
2012
Employees
10
Business model
B2B

Tech stack

Detected on sanoculis.com, last scanned 28 Oct 2026.

Frontend
jQuery
CMS / Builders
Shopify
CDN
Cloudflare
Email provider
Google Workspace
Accessibility
UserWay

Sanoculis scores 11. Does yours?

That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.

Add first review

Frequently asked

Is Sanoculis trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Sanoculis is 83 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How many employees does Sanoculis have?

Sanoculis has approximately 10 people on record.